Spectra Laboratories announces plans for new laboratory in Southaven, creating more than 300 jobs

Jackson, Miss. (Sept. 5, 2019) Spectra Laboratories, a wholly owned subsidiary of Fresenius Medical Care North America, the nation’s leading provider of kidney care products and services, broke ground on a 200,000-square-foot laboratory in Southaven. The project is expected to create more than 300 jobs over the next three years.

“The state of Mississippi is proud to partner with Spectra Laboratories as the company brings significant new job opportunities to DeSoto County,” Gov. Phil Bryant said. “The health care industry is a prominent economic driver in our state, and Spectra Laboratories and its employees will positively impact the North Mississippi region and further strengthen our foothold in this important sector for years to come.”

Fresenius Medical Care North America is a leading provider of kidney care products and services for individuals with chronic renal conditions. Spectra Laboratories offers renal-specific laboratory services, using state-of-the-art equipment, automated specimen processing and reporting applications. At Spectra’s new build-to-suit facility, which will be located in the Stateline Business Park, employees will conduct comprehensive testing, analysis and reporting to ensure the best possible outcomes for patients.

“We are excited to make Southaven the home for our newest state-of-the-art Spectra Laboratories facility,” said Rice Powell, chief executive officer of Fresenius Medical Care North America. “Our patients depend on timely and accurate lab results to manage kidney failure with life-sustaining dialysis treatments. We feel that Mississippi understands our mission and will help us deliver the reliability and personal service required to ensure we are providing the best care for our patients.”

The Mississippi Development Authority is providing assistance for workforce training and and site improvements. MDA also is supporting the project through the Advantage Jobs and Healthcare Industry Zone Incentive programs. The city of Southaven is providing assistance with a new traffic signal, and the city and DeSoto County are providing partial property tax exemptions to Spectra Laboratories.

“Spectra Laboratories’ new location has the advantage of North Mississippi’s robust transportation network, which gives the company efficient delivery of test results, enabling patients to receive the specific care they need in a timely manner,” said MDA Executive Director Glenn McCullough, Jr. “The leadership of the DeSoto County Economic Development Council, the DeSoto County Board of Supervisors, the city of Southaven and Entergy Corporation were all instrumental in bringing more than 300 new career opportunities to Mississippians in DeSoto County.”

Spectra Laboratories supports more than 250,000 patients and performs more than 70 million tests each year. The company plans to begin operations in Southaven after construction is completed. To learn more, visit spectra-labs.com.

### 

About Mississippi Development Authority

Mississippi Development Authority is the state’s lead economic and community development agency. MDA focuses on new business recruitment, existing business expansion, workforce training, and tourism promotion. For more information, visit MDA’s website at mississippi.org.

About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com.

 

 

Latest News Release